Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-42253432 is an oral active P2X7 antagonist capable of penetrating the central nervous system with a pKi value of 9.1 for rat and 7.9 for human P2X7 channels.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 197.00 | |
5 mg | In stock | $ 513.00 | |
10 mg | In stock | $ 747.00 | |
25 mg | In stock | $ 1,160.00 | |
50 mg | In stock | $ 1,560.00 | |
100 mg | In stock | $ 2,080.00 | |
500 mg | In stock | $ 4,220.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 565.00 |
Description | JNJ-42253432 is an oral active P2X7 antagonist capable of penetrating the central nervous system with a pKi value of 9.1 for rat and 7.9 for human P2X7 channels. |
Targets&IC50 | P2X7:9.1(pKi, rat), P2X7:7.9(pKi, human) |
Molecular Weight | 446.63 |
Formula | C28H38N4O |
CAS No. | 1428327-35-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90.0 mg/mL (201.5 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-42253432 1428327-35-8 Membrane transporter/Ion channel Neuroscience P2X Receptor JNJ 42253432 JNJ42253432 inhibitor inhibit